GCOW - ETF AI Analysis

Top Page

Pacer Global Cash Cows Dividend ETF (GCOW)

Rating:68Neutral

Price Target:―

The Pacer Global Cash Cows Dividend ETF (GCOW) has a solid overall rating, reflecting its focus on financially strong companies with positive growth prospects. Top holdings like Johnson & Johnson and Merck contribute significantly to the fund’s performance due to their strong financial results, strategic initiatives, and bullish outlooks. However, weaker holdings such as BP and AbbVie, which face valuation and financial stability challenges, slightly weigh down the fund’s score. A key risk factor is the potential overvaluation in some holdings, which may limit future growth.

Positive Factors

Strong Top Holdings

Several key positions, such as Johnson & Johnson and AbbVie, have shown strong year-to-date performance, supporting the ETF’s overall returns.

Global Diversification

The ETF invests across multiple countries, including the USA, UK, France, and Japan, reducing reliance on any single market.

Healthy Sector Balance

The fund is diversified across sectors like Health Care, Energy, and Consumer Defensive, helping to mitigate risks from sector-specific downturns.

Negative Factors

Moderate Expense Ratio

The ETF’s expense ratio is higher than some low-cost alternatives, which could reduce long-term returns for investors.

Underperforming Holdings

Some top holdings, such as PepsiCo and Chevron, have shown weaker year-to-date performance compared to others in the portfolio.

Limited Technology Exposure

The fund has minimal exposure to the Technology sector, which could limit growth potential in a tech-driven market environment.

GCOW vs. SPDR S&P 500 ETF (SPY)

AUM2.64B

RegionDeveloped Markets

Expense Ratio0.60%

Beta0.39

IssuerPacer

Inception DateFeb 23, 2016

Dividend Yield2.46%

Asset ClassEquity

Index TrackedPacer Global Cash Cows Dividend Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume189,492

30 Day Avg. Volume160,579

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

45.31

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering97

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

GCOW Summary

The Pacer Global Cash Cows Dividend ETF (GCOW) is an investment fund that focuses on large, financially strong companies worldwide that generate high free cash flow and pay consistent dividends. It includes well-known names like Johnson & Johnson and PepsiCo, and covers industries such as healthcare, energy, and consumer goods. This ETF is ideal for investors seeking steady income through dividends and global diversification, while also offering potential for growth. However, new investors should note that its performance can fluctuate with the broader market and global economic conditions.

How much will it cost me?The Pacer Global Cash Cows Dividend ETF (GCOW) has an expense ratio of 0.6%, which means you’ll pay $6 per year for every $1,000 invested. This is higher than average because the fund is actively managed, focusing on selecting companies with strong free cash flow yields to provide consistent dividends. The higher cost reflects the strategic approach and specialized research involved in managing the fund.

What would affect this ETF?The Pacer Global Cash Cows Dividend ETF (GCOW) could benefit from stable demand in defensive sectors like Health Care and Consumer Defensive, which make up a significant portion of its holdings, especially during economic uncertainty. However, its exposure to Energy and Materials sectors may face challenges if commodity prices decline or if stricter environmental regulations impact profitability. Additionally, global economic conditions and interest rate changes could influence the performance of its large-cap multinational holdings.

GCOW Top 10 Holdings

The Pacer Global Cash Cows Dividend ETF (GCOW) leans heavily on health care and energy stocks, with names like Johnson & Johnson and Roche Holding driving steady performance thanks to strong cash flow and strategic growth initiatives. Meanwhile, British American Tobacco has been a bright spot for income seekers, despite mixed momentum. On the flip side, PepsiCo has been lagging, holding back gains with recent underperformance. With its focus on developed markets and a tilt toward defensive sectors, this fund offers a stable, income-oriented approach, though some holdings face valuation and technical headwinds.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
JNJ	Johnson & Johnson	2.35%	$61.93M	$486.51B	35.24%	80 Outperform
MRK	Merck & Company	2.30%	$60.65M	$247.51B	-3.27%	81 Outperform
BP	BP p.l.c.	2.28%	$60.25M	£69.34B	19.88%	71 Outperform
RIO	Rio Tinto	2.24%	$59.07M	£94.54B	11.70%	82 Outperform
BATS	British American Tobacco	2.19%	$57.77M	£93.12B	44.30%	71 Outperform
MBG	Mercedes-Benz Group	2.16%	$57.17M	€59.24B	26.29%	77 Outperform
ABBV	AbbVie	2.16%	$57.11M	$399.57B	28.32%	65 Neutral
BHP	BHP Group Ltd	2.13%	$56.33M	£113.38B	13.95%	68 Neutral
ROG	Roche Holding AG	2.13%	$56.28M	CHF248.72B	32.86%	73 Outperform
AMGN	Amgen	2.10%	$55.58M	$177.64B	21.02%	77 Outperform

GCOW Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

40.35

Positive

100DMA

39.80

Positive

200DMA

38.18

Positive

Market Momentum

MACD

0.39

Negative

RSI

62.27

Neutral

STOCH

83.45

Negative

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GCOW, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 41.12, equal to the 50-day MA of 40.35, and equal to the 200-day MA of 38.18, indicating a bullish trend. The MACD of 0.39 indicates Negative momentum. The RSI at 62.27 is Neutral, neither overbought nor oversold. The STOCH value of 83.45 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GCOW.

GCOW Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
GCOW	―	―	$2.64B	0.60%	―
URTH	―	―	$6.58B	0.24%	―
GLOV	―	―	$1.53B	0.25%	―
WSML	―	―	$769.93M	0.30%	―
GDIV	―	―	$218.07M	0.50%	―
IQSI	―	―	$211.94M	0.15%	―

Performance Comparison

GCOW

Pacer Global Cash Cows Dividend ETF

41.56

7.23

21.06%

URTH

iShares MSCI World ETF

―

GLOV

Goldman Sachs ActiveBeta World Low Vol Plus Equity ETF

―

WSML

iShares MSCI World Small-Cap ETF

―

GDIV

Harbor Dividend Growth Leaders ETF

―

IQSI

IQ Candriam ESG International Equity ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents